
Selvita S.A. — Investor Relations & Filings
Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Voting form | 2026-05-28 | English | |
| Supervisory Board's Resolutions | 2026-05-28 | English | |
| Remuneration report | 2026-05-28 | English | |
| Remuneration report-Auditor | 2026-05-28 | English | |
| Power of Attorney (natural person) | 2026-05-28 | English | |
| Power of Attorney (legal person) | 2026-05-28 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47864771 | Voting form | 2026-05-28 | English | ||
| 47864770 | Supervisory Board's Resolutions | 2026-05-28 | English | ||
| 47864769 | Remuneration report | 2026-05-28 | English | ||
| 47864768 | Remuneration report-Auditor | 2026-05-28 | English | ||
| 47864767 | Power of Attorney (natural person) | 2026-05-28 | English | ||
| 47864766 | Power of Attorney (legal person) | 2026-05-28 | English | ||
| 47864764 | Consolidated Financial Statements | 2026-05-28 | English | ||
| 47864763 | Sustainability Report - Auditor | 2026-05-28 | English | ||
| 47864762 | Consolidated Financial Report - Auditor | 2026-05-28 | English | ||
| 47864761 | Annual Report Sustainability Report | 2026-05-28 | English | ||
| 47864760 | Annual Report | 2026-05-28 | English | ||
| 47864758 | GSM Resolutions | 2026-05-28 | English | ||
| 47864757 | Convening | 2026-05-28 | English | ||
| 47864756 | Wniosek Zarządu - podział zysku / Allocation of profit resolution | 2026-05-28 | Polish | ||
| 47864755 | Uchwały Rady Nadzorczej | 2026-05-28 | Polish | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Selvita S.A., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
Selvita S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5808/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5808 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5808 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5808 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5808}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Selvita S.A. (id: 5808)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.